Theraclion SA
Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize imag… Read more
Market Cap & Net Worth: Theraclion SA (TCLIF)
Theraclion SA (PINK:TCLIF) has a market capitalization of $11.82K ($11.82K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46069 globally and #14398 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Theraclion SA's stock price $0.00 by its total outstanding shares 59081130 (59.08 Million).
Theraclion SA Market Cap History: 2019 to 2025
Theraclion SA's market capitalization history from 2019 to 2025. Data shows change from $111.83 Million to $11.82K (-77.77% CAGR).
Theraclion SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Theraclion SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Theraclion SA's market cap is 0.01 times its annual revenue
0.74x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $111.83 Million | $2.78 Million | -$3.79 Million | 40.17x | N/A |
| 2020 | $144.75 Million | $744.00K | -$3.90 Million | 194.55x | N/A |
| 2021 | $134.70 Million | $1.48 Million | -$3.76 Million | 90.96x | N/A |
| 2022 | $134.70 Million | $1.24 Million | -$4.96 Million | 109.03x | N/A |
| 2023 | $134.70 Million | $1.82 Million | -$3.68 Million | 73.92x | N/A |
| 2024 | $11.82K | $830.00K | -$5.76 Million | 0.01x | N/A |
Competitor Companies of TCLIF by Market Capitalization
Companies near Theraclion SA in the global market cap rankings as of March 19, 2026.
Key companies related to Theraclion SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Theraclion SA Historical Marketcap From 2019 to 2025
Between 2019 and today, Theraclion SA's market cap moved from $111.83 Million to $ 11.82K, with a yearly change of -77.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $11.82K | 0.00% |
| 2024 | $11.82K | -99.99% |
| 2023 | $134.70 Million | 0.00% |
| 2022 | $134.70 Million | 0.00% |
| 2021 | $134.70 Million | -6.94% |
| 2020 | $144.75 Million | +29.43% |
| 2019 | $111.83 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Theraclion SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.82K USD |
| MoneyControl | $11.82K USD |
| MarketWatch | $11.82K USD |
| marketcap.company | $11.82K USD |
| Reuters | $11.82K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.